Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 4.440
-0.120 (-2.63%)
Jul 21, 2026, 5:00 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 68.69 million as of July 21, 2026. Its market cap has decreased by -27.69% in one year.
Market Cap
68.69M
Enterprise Value
67.95M
Revenue
30.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.44
ChartMarket Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 68.69M, a decrease of -37.86%. That is a compound annual growth rate of -8.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 68.69M | 20.00% |
| Dec 30, 2025 | 57.25M | -45.34% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synektik Spólka Akcyjna | 3.29B |
| Medinice | 664.92M |
| Medicalgorithmics | 268.72M |
| Milton Essex Spólka Akcyjna | 50.38M |
| Nestmedic | 39.84M |
| InventionMed | 21.19M |
| Adiuvo Investments | 5.44M |
| Zortrax | 1.21M |